Latest ebit for SFBE: $-1, below the sector sector average of $2.4T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2024
Trailing 12 months ending Jun 30, 2024
As of the most recent data (June 2024), SFBE shows a EBIT of $-1. That compares with $-490K in the prior-year period — up 100.0% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SFBE's EBIT is now $-1 (was $-490K) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sino Bioenergy is outperforming or lagging.
The its sector sector average EBIT is about $2.4T. Sino Bioenergy is at $-1, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how SFBE stacks up against individual peers as well.
Tracking SFBE's ebit over time shows whether Sino Bioenergy is scaling, shrinking, or reshaping that part of the business. The current reading is $-1 That compares with $-490K in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Sino Bioenergy's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-1) with ownership activity and broader fundamentals.